3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Myelodysplastic Syndromes
8
Advanced Solid Tumors
8
Myeloproliferative Disorders
5
Leukemia, Myelomonocytic, Chronic
5
Neoplasms
4
Multiple Myeloma
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumour
4
Advanced Solid Tumor
4
Small Cell Lung Carcinoma
3
Recurrence
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Leukemia, Monocytic, Acute
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Neoplasm Metastasis
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Malignant Solid Tumor
2
Advanced Lung Cancer
2
Interventions
Gemcitabine
15
Cisplatin
13
durvalumab
10
pembrolizumab
9
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Specimen Handling
6
Leucovorin
6
Biopsy
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
futibatinib
2
fludarabine
2
dehydroftorafur
2
Platinum
2
Liver Transplantation
2
Fluorodeoxyglucose F18
2
Floxuridine
2
Dexamethasone
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Injections
×
90 days
×
Clear all
No trials found.